QCORE Stock Overview
Qlucore AB (publ) provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Qlucore AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr8.15 |
| 52 Week High | kr14.30 |
| 52 Week Low | kr5.75 |
| Beta | 0.41 |
| 1 Month Change | -3.55% |
| 3 Month Change | 12.41% |
| 1 Year Change | -39.63% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -85.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| QCORE | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | 0.6% | 3.3% | 0.9% |
| 1Y | -39.6% | 31.1% | 10.3% |
Return vs Industry: QCORE underperformed the Swedish Healthcare Services industry which returned 30.4% over the past year.
Return vs Market: QCORE underperformed the Swedish Market which returned 10.7% over the past year.
Price Volatility
| QCORE volatility | |
|---|---|
| QCORE Average Weekly Movement | 10.4% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: QCORE has not had significant price volatility in the past 3 months.
Volatility Over Time: QCORE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 22 | Carl-Johan Ivarsson | www.qlucore.com |
Qlucore AB (publ) provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for multi-omics companion. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Qlucore AB (publ) Fundamentals Summary
| QCORE fundamental statistics | |
|---|---|
| Market cap | kr32.83m |
| Earnings (TTM) | -kr15.07m |
| Revenue (TTM) | kr39.73m |
0.8x
P/S Ratio-2.2x
P/E RatioIs QCORE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QCORE income statement (TTM) | |
|---|---|
| Revenue | kr39.73m |
| Cost of Revenue | kr29.42m |
| Gross Profit | kr10.31m |
| Other Expenses | kr25.38m |
| Earnings | -kr15.07m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | -3.74 |
| Gross Margin | 25.95% |
| Net Profit Margin | -37.93% |
| Debt/Equity Ratio | 4.2% |
How did QCORE perform over the long term?
See historical performance and comparison